Products

SonoVision Ultrasound Imaging System
Tissue Differentiation Intelligence
Radiology & Imaging AI
SonoVision by Tissue Differentiation Intelligence is an FDA-cleared, AI-enabled ultrasound system providing real-time visualization and differentiation of nerve, muscle, bone, and vessels for intraoperative use in spine surgery.

See all 1 product →

About Tissue Differentiation Intelligence

Tissue Differentiation Intelligence (TDi) is a healthcare AI company that has developed technology to transform conventional two-dimensional black-and-white ultrasound images into three-dimensional color visualizations. This innovative platform leverages machine learning algorithms to provide enhanced differentiation of anatomical structures.

For physicians, TDi’s technology is particularly relevant in minimally invasive (MIS) spine surgery. The system is designed to visualize and differentiate critical structures such as sensory and motor nerves, as well as vascular networks, in real time during procedures. This aims to provide surgeons with a clearer and more intuitive understanding of the surgical field, potentially improving therapeutic and diagnostic accuracy and enhancing patient safety by overcoming the limitations of traditional ultrasound in complex anatomical regions.

Focus Areas

Real-time surgical ultrasound imaging AI for tissue differentiation machine learning in surgery spine surgery minimally invasive surgery neurovascular structure detection

Business Intelligence

Key InvestorsLakeshore Capital Partners
TechnologyAI-enhanced ultrasound imaging system (SonoVision) utilizing machine learning and image-processing algorithms for real-time visual differentiation of nerves, muscle, bone, and vessels based on image characteristics and spectral signatures.
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Real-time Surgical Ultrasound Imaging
Tissue Differentiation Intelligence (TDi) specializes in providing real-time intraoperative ultrasound imaging through its SonoVisionu2122 platform. This system is designed to offer immediate visualization of anatomical structures during surgery.
AI for Tissue Differentiation
The SonoVisionu2122 platform leverages advanced AI and machine learning algorithms to accurately detect, segment, and classify different tissue types, including nerve, muscle, bone, and vessels, in real-time.
Machine Learning in Surgery
TDi's SonoVisionu2122 is noted as the first machine learning-enabled ultrasound product specifically designed for intraoperative access to the spine, marking a significant advancement in surgical technology.
Spine Surgery Focus
The company's primary application area is spine surgery, particularly in procedures like lateral lumbar interbody fusion (LLIF), where precise identification of neurovascular structures is critical.
Minimally Invasive Surgery Enhancement
SonoVisionu2122 aims to address the technology gap in intuitive, real-time soft-tissue imaging during minimally invasive spine procedures, thereby facilitating their adoption and safety.
Neurovascular Structure Detection
A key specialization is the highly accurate detection, segmentation, classification, and display of critical neural and neurovascular structures, providing surgeons with a visual map of important anatomy.
Key Differentiator: First ML-Enabled Ultrasound for Spine
SonoVisionu2122 stands out as the pioneering machine learning-enabled ultrasound system specifically cleared for intraoperative use in spine surgery.
Key Differentiator: Intuitive Color Differentiation
The system provides intuitive color differentiation of nerve, muscle, bone, and vessels in real-time, making complex anatomical structures easily distinguishable for surgeons.
Key Differentiator: High Accuracy & Validation
Validated through in-vivo porcine studies, the AI-trained system demonstrated high sensitivity and specificity, with over 95% accuracy for nerve detection and a mean Dice coefficient score of >80% for tissue types.
Technology Stack: SonoVisionu2122 Platform
The core technology includes the SonoVisionu2122 console, monitor, and the Beluga1u2122 ultrasound probe, which is a 10 MHz linear array transducer designed for intraoperative use.
Technology Stack: AI & Image Processing
The platform integrates proprietary image processing and machine learning algorithms that operate on B-mode ultrasound images to perform real-time tissue analysis and display.
Physician Tip

For physicians, Tissue Differentiation Intelligence's SonoVisionu2122 platform offers a significant advancement in surgical guidance, particularly in spine surgery. Its real-time, AI-enhanced ultrasound imaging provides an unprecedented visual map of critical neural and vascular anatomy, which can substantially enhance surgical safety by reducing the risk of iatrogenic injury during complex procedures. The intuitive color differentiation of tissues (nerves, muscles, bone, vessels) addresses a long-standing challenge in visualizing soft tissues during minimally invasive approaches, allowing for more confident and precise surgical maneuvers. This technology can also potentially contribute to reducing radiation exposure for both patients and surgical staff by offering a viable alternative or complement to fluoroscopy. The objective tissue identification capabilities, backed by high accuracy rates, empower surgeons with better, more informed decision-making tools intraoperatively, ultimately aiming to improve patient outcomes and facilitate the adoption of advanced minimally invasive techniques.

Tissue Differentiation Intelligence is actively working on expanding the procedural applications of SonoVisionu2122, including posterior access to the spine, 3D imaging, and integration with image-guided navigation systems. Future plans also include integration with other technologies, such as robotics, to further enhance operating room capabilities.

Products by Tissue Differentiation Intelligence

1 product in the directory

SonoVision Ultrasound Imaging System
Tissue Differentiation Intelligence
Radiology & Imaging AI
SonoVision by Tissue Differentiation Intelligence is an FDA-cleared, AI-enabled ultrasound system providing real-time visualization and differentiation of nerve, muscle, bone, and vessels for intraoperative use in spine surgery.

What the Web Says

Tissue Differentiation Intelligence (TDi) is a healthcare AI company that has developed the SonoVisionu2122 Ultrasound Imaging System, an FDA-cleared device designed to enhance tissue differentiation during orthopedic and neurological surgeries, particularly in minimally invasive procedures. The system utilizes AI-enhanced ultrasound imaging to help surgeons identify various tissue structures, such as nerves, bone, and muscle. While the technology shows promise in improving surgical accuracy and reducing complications, direct user and employer reviews on major platforms like G2, Glassdoor, and Capterra are limited.

Overall: Mixed

Strengths

  • AI-enhanced ultrasound imaging for accurate tissue differentiation.
  • FDA-cleared device, indicating regulatory approval for medical use.
  • Aids in minimally invasive surgeries where direct visual and haptic feedback are limited.
  • Demonstrated high accuracy (over 95% for nerve detection) and sensitivity (>95% for nerve, bone, and muscle) in animal studies.
  • Potential to reduce surgical complications by improving tissue identification.
  • Associated with experienced individuals in the spine and MedTech industry.

Limitations

  • Limited direct user reviews on major platforms (G2, Glassdoor, Capterra).
  • Lack of extensive public product reviews from healthcare IT reviewers or Reddit.
  • Specific employer reviews are not readily available.
  • The systematic review noted that some intraoperative tissue classification methods can have poor performance in inter-patient evaluations.
  • The technology is primarily discussed in academic and medical conference contexts, suggesting it may be early in its broader market adoption.
  • No information found regarding pricing or accessibility of the product.

Based on reviews from: G2, Glassdoor, Capterra, PubMed Central (PMC), Notable Health, Oracle Health, accessdata.fda.gov, Spine, HSS eAcademy, HealthAidb, Talanoa: At the heart of MedTech Recruitment., HSS, Journal of Spine Surgery, ISASS - The International Society for the Advancement of Spine Surgery, DukeSpace, Neurospine, AME Publishing Company, Scoliosis Research Society, ResearchGate

Last updated: 2026-07-19

Videos

News, demos, and interviews about Tissue Differentiation Intelligence.

Loading videos...

Videos load interactively. If none appear, search YouTube for Tissue Differentiation Intelligence →

View all on YouTube

Press & Coverage

PR Newswire
TDiu2122 | SonoVisionu2122 Receives 510(k) Clearance for the First Machine Learning Enabled Ultrasound Product in Spine Surgery
Tissue Differentiation Intelligence, LLC (TDiu2122) announced receiving 510(k) clearance for its SonoVisionu2122 ultrasound platform, the first machine learning-enabled ultrasound product for intraoperative access to the spine. This technology visually differentiates nerve, muscle, bone, and vessels in real time during spine surgery.
2020-04
AuntMinnie.com
FDA OKs TDI's ultrasound platform
The FDA has granted 510(k) clearance to Tissue Differentiation Intelligence (TDI) for its SonoVision ultrasound platform, designed for real-time surgical ultrasound imaging during spine procedures. The system uses color to differentiate nerves, muscle, and bone, and applies image-processing algorithms for real-time acquisition.
2020-04
Healio
FDA clears machine learning-enabled ultrasound platform for spine access
Tissue Differentiation Intelligence LLC's SonoVision, a machine learning-enabled ultrasound product for intraoperative spine access, has received FDA 510(k) clearance. The platform uses image-processing algorithms to display real-time color differentiation of nerves, muscles, and bones.
2020-04
Medimaging.net
AI Enabled Ultrasound Device Advances Spine Surgery
Tissue Differentiation Intelligence (TDi) has developed the SonoVision ultrasound imaging system, an AI-enabled real-time surgical ultrasound platform for intraoperative imaging in spinal procedures. This system differentiates nerve, muscle, bone, and vessels in real time using image processing software.
2020-04
Spine
Artificial Intelligence-enabled, Real-time Intraoperative Ultrasound Imaging of Neural Structures Within the Psoas
This study, published in Spine, details the development and validation of image processing and machine learning algorithms by Tissue Differentiation Intelligence (USA) to detect neural and other anatomical structures within and adjacent to the psoas muscle during lateral lumbar spine surgery using the SonoVisionu2122 ultrasound imaging system.
2021-02
Orthopedic Design & Technology (ODT)
Future Stars of the Spine Industry: The Companies to Watch, 2021
TDi (Tissue Differentiation Intelligence) is highlighted as a company to watch in 2021 for its AI-driven intraoperative soft-tissue imaging technology, SonoVision, designed for spine surgery. The platform uses machine learning on real-time ultrasonic images to provide surgeons with a clear view of soft-tissue structures.
2021-09
Frontiers in Surgery
Intraoperative tissue classification methods in orthopedic and neurological surgeries: A systematic review
A systematic review of intraoperative tissue classification methods in orthopedic and neurological surgeries mentions Tissue Differentiation Intelligence's SonoVisionu2122 ultrasound imaging system as a technology used for differentiating tissue types.
2022-07
PitchBook
Tissue Differentiation Intelligence 2026 Company Profile
Tissue Differentiation Intelligence has raised $6 million in funding, with Lakeshore Capital Partners identified as an investor. The company provides technology that converts traditional 2D ultrasound into 3D color images using machine learning for therapeutic and diagnostic applications in minimally invasive spine surgery.
unknown

Frequently Asked Questions

TDi's core technology is the SonoVisionu2122 Ultrasound Platform, which employs advanced image-processing algorithms and machine learning to provide real-time, intuitive color differentiation of tissues like nerves, muscle, bone, and vessels during surgery. This AI-enhanced ultrasound system aims to overcome the limitations of conventional ultrasound by visually mapping critical anatomy.
SonoVisionu2122 is designed for intraoperative access to the spine, visually differentiating neurovascular structures in real-time to help surgeons avoid damage during minimally invasive procedures. By providing a clear, color-coded map of nerves, vessels, muscle, and bone, it aims to increase the safety and precision of surgeries like lateral lumbar interbody fusion (LLIF).
TDi's SonoVisionu2122 Ultrasound Platform received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in April 2020. This clearance allows its use as a general-purpose ultrasound system for visualizing and evaluating nerves, vascular, and other anatomical structures, particularly in spine procedures.
TDi is actively developing expanded procedural applications for SonoVisionu2122, including posterior access to the spine, 3D imaging capabilities, and integration with image-guided navigation systems. These advancements are in earlier stages of procedural development, aiming to broaden the system's utility in various surgical settings.
While specific details on ongoing support and training programs are not extensively detailed in public releases, TDi has deployed systems for clinical study data collection and Alpha evaluations focused on clinical refinement. This suggests a commitment to ensuring effective integration and use, likely involving product specialists and educational resources.
Specific pricing models or acquisition processes for the SonoVisionu2122 platform are not publicly disclosed in the provided search results. Healthcare administrators interested in this information would need to contact Tissue Differentiation Intelligence directly for details on purchasing, leasing, or other financial arrangements.
Tissue Differentiation Intelligence (TDi) has secured investment from Lakeshore Capital Partners, indicating some financial backing. While the primary press releases are from 2019-2020 regarding FDA clearance and awards, further recent details on company stability or new strategic partnerships are not publicly available in the provided search results.

Related Companies

Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]

TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]

TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]

Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]

Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]

SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.